The impact that external events like the COVID-19 pandemic can have on clinical trials, as well as a company’s entire drug development portfolio, can be far reaching. Tracking metrics associated with these crises is essential to enable study teams to follow global trends of the impact. The ability to adapt to configurations such as sponsor-specific metrics labels, thresholds for key performance indicators (KPIs) and quality tolerance limits (QTLs) are necessities to ensure successful trial oversight in an ever-changing clinical trial environment.
Join this informative webinar where presenters will discuss how integrating data sources and reporting on metrics and KPIs in a thoughtful and clear way can enable study teams to quickly ascertain the health of a study or group of studies in crisis circumstances. A case study demonstrating the tracking of metrics important to COVID-19 will also be presented.
Kristin Stallcup, MS, PMP, Senior Director, Xcellerate Customer Success, Covance Inc.
Kristin brings 15 years of experience in various trial management capacities to her role as senior director for implementation and business process adoption of the Covance Xcellerate® suite. She previously led development and implementation of Xcellerate Risk and Issue Management, and Xcellerate monitoring methodology and technology implementation. Kristin holds an MSHS in clinical research management from George Washington University, a BS in molecular biology from Vanderbilt University, and Project Management Professional (PMP) certification.
Joanna K. Bernstein, MS, Director, Xcellerate Customer Success, Covance Inc.
Joanna Bernstein has 20 years of clinical trial management experience, spanning from clinical research associate through project director. In her current role, she is responsible for the implementation, business process adoption and support of various Covance Xcellerate® products including the Xcellerate Portal, Xcellerate Study Dashboard, Xcellerate CRA Dashboard and Xcellerate Portfolio Dashboard. Joanna holds an MS and BS in biology with a concentration in biotechnology from Fairleigh Dickinson University.
Who Should Attend?
What You Will Learn
In this webinar, attendees will learn about:
- Creating flexible metrics to meet critical sponsor and CRO needs in a time of crisis
- Gauging the impact of external events on KPIs
- Comparing milestone performance
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives.
Covance is a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services. Our unique perspectives are based on decades of scientific, medical, and regulatory expertise. We generate more safety and efficacy data to support drug approvals than any other company, supporting our clients’ complete lifecycle management.
Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions. Visit us at www.covance.com.